[Surgical innovations in the treatment of benign prostatic hyperplasia: towards new standard treatments?].
Indications for surgical treatment of benign prostatic hyperplasia (BPH) are consensual. Surgery is reserved for cases of complicated BPH and failures of medical treatment with moderately to severely disabling LUTS. New techniques of minimally invasive resection, suitable for relatively small prostate volumes, are being developed as alternatives to transurethral resection of the prostate (TURP). Transurethral vaporisation of the prostate (TUVP), transurethral laser photoselective vaporisation of the prostate (PVP), thermal resection of the prostate, microwave treatment and Holmium laser enucleation/vaporisation of the prostate show promising preliminary results in these indications. However, these results must be confirmed in the long-term before these methods can be considered to be valid alternatives to TURP.
Cornu
Jean-Nicolas
JN
Service d'Urologie de l'Hôpital Pitié-Salpêtrière, Paris, France.
Rouprêt
Morgan
M
D006801:Humans; D008297:Male; D011468:Prostatectomy / Q000379:methods; D011470:Prostatic Hyperplasia / Q000601:surgery* / Q000628:therapy; D017211:Treatment Failure; D014521:Urethra / Q000601:surgery